PO-628-03 ASSOCIATION OF MINERALOCORTICOID RECEPTOR ANTAGONIST USE WITH MORTALITY AND VENTRICULAR ARRHYTHMIA RISK IN PATIENTS WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
Ramya Sampath(University of Rochester Medicine), Himabindu Vidula(University of Rochester Medicine), Mehmet K. Aktaş(University of Rochester Medical Center), Valentina Kutyifa, Alexander Diamond(University of Rochester Medicine), Ilan Goldenberg(Sheba Medical Center), Anita Y. Chen(University of Rochester Medicine), Scott McNitt(University of Rochester), Wojciech Zaręba(University of Rochester Medical Center), Hillel Steiner(University of Manchester), Milica Bjelic(Boston University)
Cited by 0
Related Papers
Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
|Circulation|2010|2.7k
Genotype-Phenotype Correlation in the Long-QT Syndrome
|Circulation|2001|1.8k
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: Proposed Modification of the Task Force Criteria
|European Heart Journal|2010|1.6k
Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction
|Circulation|2009|1k
Gender disparities in the diagnosis and treatment of non–ST-segment elevation acute coronary syndromes
|Journal of the American College of Cardiology|2005|658